Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom

Journal article

Vihta KD. et al, (2022), Clinical Infectious Diseases, 75, e329 - e337

Catwalk: identifying closely related sequences in large microbial sequence databases.

Journal article

Volk D. et al, (2022), Microbial genomics, 8

Mycobacterium tuberculosis transmission in Birmingham, UK, 2009–19: An observational study

Journal article

Walker TM. et al, (2022), The Lancet Regional Health - Europe, 17, 100361 - 100361

Mycobacterium tuberculosis transmission in Birmingham, UK, 2009–19: An observational study

Journal article

Walker TM. et al, (2022), The Lancet Regional Health - Europe, 17, 100361 - 100361

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.

Journal article

Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18

Whole genome sequencing reveals hidden transmission of carbapenemase-producing Enterobacterales.

Journal article

Marimuthu K. et al, (2022), Nature communications, 13

Realising the Potential of Genomics for M. tuberculosis: A Silver Lining to the Pandemic?

Journal article

Walker TM. and Crook DW., (2022), China CDC Weekly, 4, 437 - 439

Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance

Journal article

Pritchard E. et al, (2022), The Lancet Regional Health - Europe, 13, 100282 - 100282

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Journal article

Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.

Journal article

Dejnirattisai W. et al, (2021), Lancet (London, England)

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.

Journal article

Elliott P. et al, (2021), Science (New York, N.Y.), 374

Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom

Journal article

Walker AS. et al, (2021), New England Journal of Medicine

Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers

Journal article

Wang W. et al, (2021), Journal of Biological Rhythms, 074873042110593 - 074873042110593

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

Journal article

Townsend A. et al, (2021), Nature Communications, 12

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

Journal article

Wei J. et al, (2021), Nature Communications, 12

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Journal article

Pouwels KB. et al, (2021), Nature Medicine, 27, 2127 - 2135

Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections

Journal article

Eyre DW. et al, (2021), BMC Infectious Diseases, 21

An end-to-end heterogeneous graph attention network for Mycobacterium tuberculosis drug-resistance prediction

Journal article

Yang Y. et al, (2021), Briefings in Bioinformatics, 22

Antimicrobial resistance genes and clonal success in Escherichia coli isolates causing bloodstream infection

Journal article

Lipworth S. et al, (2021), LANCET MICROBE, 2, E492 - E492

Epidemiology of Mycobacterium abscessus in England: an observational study

Journal article

Lipworth S. et al, (2021), The Lancet Microbe, 2, e498 - e507

Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status

Journal article

Eyre DW. et al, (2021), Clinical Microbiology and Infection, 27, 1516.e7 - 1516.e14

Flanker: a tool for comparative genomics of gene flanking regions

Journal article

Matlock W. et al, (2021), Microbial Genomics, 7

Load More